| Ab | Antibody |
| DAAs | Direct acting antiviral drugs |
| ECM | Extracellular matrix |
| ER | Endoplasmic reticulum |
| HAV | Hepatitis A virus |
| HBV | Hepatitis B virus |
| HCV | Hepatitis C virus |
| HEV | Hepatitis E virus |
| HCC | Hepatocellular carcinoma |
| HSCs | Hepatic stellate cells |
| ICIs | Immune checkpoint inhibitors |
| LPS | Lipopolysaccharides |
| n | Number |
| PAMP | Pathogen-associated molecular patterns |
| PEG-IFN | Pegylated interferon |
| PNALT | Persistently normal serum alanine aminotransferase stage |
| PSC | Primary sclerosing cholangitis |
| RBV | Ribavirin |
| RdRp | RNA-dependent RNA polymerase |
| SCFAs | Short-chain fatty acids |
| SVR | Sustained virological response |
| UTR | Untranslated region |